Karyopharm Therapeutics | KPTI - Interest Income


Karyopharm Therapeutics reported $-0.15 in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
AbbVie USD 72M 13M Mar/2026
Abbott USD 106M 28M Mar/2026
AstraZeneca USD 80M 7M Jun/2026
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Eli Lilly USD 65M 25M Sep/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Incyte USD 38.12M 4.43M Jun/2026
J&J USD 2.27 0.13 Jun/2026
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.55M 26K Mar/2026
Merck USD 35M 34M Mar/2026
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pfizer USD -0.04 115M Jun/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Takeda JPY 24.61B 213.76B Jun/2026
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Ultragenyx Pharmaceutical USD 6M 512K Mar/2026
Xencor USD 5.46M 741K Mar/2026